866-997-4948(US-Canada Toll Free)

HTG Molecular Diagnostics Inc (HTGM) - Product Pipeline Analysis, 2016 Update

Published By :

GlobalData

Published Date : Dec 2016

Category :

Molecular Diagnostics

No. of Pages : 34 Pages

Summary

HTG Molecular Diagnostics Inc (HTG) is an information technology company that provides molecular technology solutions. The company offers products including HTG edge system, HTG edgeseq reagents, HTG edge system, HTG edgeseq oncology biomarker panel assay, and others. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also provides endogenous control array, custom array development, qSelect miRNA gene list, qSelect mRNA gene list, qDiscovery miRNA Version 16, clinical trial support and ingenuity IPA data analysis services. The company provides services to biomarker discovery and companion diagnostic developers. HTG is headquartered in Tucson, Arizona, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company HTG Molecular Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
HTG Molecular Diagnostics Inc Company Overview 5
HTG Molecular Diagnostics Inc Company Snapshot 5
HTG Molecular Diagnostics Inc Pipeline Products and Clinical Trials Overview 5
HTG Molecular Diagnostics Inc Pipeline Analysis Overview 7
Key Facts 7
HTG Molecular Diagnostics Inc - Major Products and Services 8
HTG Molecular Diagnostics Inc Pipeline Products by Development Stage 9
HTG Molecular Diagnostics Inc Pipeline Products Overview 11
Companion Diagnostic Test - B-Cell Malignancy 11
Companion Diagnostic Test - B-Cell Malignancy Product Overview 11
COPD Risk Stratification Test 12
COPD Risk Stratification Test Product Overview 12
Diagnostic Test - Breast Cancer 13
Diagnostic Test - Breast Cancer Product Overview 13
Diagnostic Test - Lung Cancer 14
Diagnostic Test - Lung Cancer Product Overview 14
Diagnostic Test - Lymphoma 15
Diagnostic Test - Lymphoma Product Overview 15
Diagnostic Test - Melanoma 16
Diagnostic Test - Melanoma Product Overview 16
Heart Transplant Rejection Blood Test 17
Heart Transplant Rejection Blood Test Product Overview 17
HTG EdgeSeq ALKPlus Assay 18
HTG EdgeSeq ALKPlus Assay Product Overview 18
HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 19
HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 Product Overview 19
HTG JANUS 20
HTG JANUS Product Overview 20
I/O Suite 21
I/O Suite Product Overview 21
Ion PGM Dx System - Cancer Assay 22
Ion PGM Dx System - Cancer Assay Product Overview 22
Ion PGM Dx System - Genetic Disorder Assay 23
Ion PGM Dx System - Genetic Disorder Assay Product Overview 23
NGS-based Theranostic Tool 24
NGS-based Theranostic Tool Product Overview 24
HTG Molecular Diagnostics Inc - Key Competitors 25
HTG Molecular Diagnostics Inc - Key Employees 26
HTG Molecular Diagnostics Inc - Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
HTG Molecular Diagnostics Inc, Recent Developments 28
Nov 14, 2016: HTG Molecular Diagnostics Reports Third Quarter 2016 Results 28
Aug 29, 2016: Dr. Ann Hanham Joins HTG Molecular Diagnostics Board of Directors 28
Aug 09, 2016: HTG Molecular Diagnostics Reports Second Quarter 2016 Results 29
Jul 20, 2016: HTG Molecular Diagnostics Obtains CE IVD Mark for Its HTG EdgeSeq System 29
Jul 20, 2016: HTG Molecular Diagnostics Obtains CE IVD Mark for Its HTG EdgeSeq DLBCL Cell of Origin Assay 29
Jun 23, 2016: HTG Molecular Diagnostics Announces VERI/O Laboratory Service 30
Jun 20, 2016: HTG Molecular Appoints New Vice President of North American Capital Sales for the HTG EdgeSeq Platform 30
Jun 06, 2016: HTG Molecular Diagnostics and Cancer Genetics Announce Presentation of an Immuno-Oncology Study at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting 31
May 12, 2016: HTG Molecular Diagnostics Reports First Quarter 2016 Results 31
May 03, 2016: Don Hardison Joins the Board of Directors for HTG Molecular Diagnostics 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
HTG Molecular Diagnostics Inc Pipeline Products and Clinical Trials Overview 5
HTG Molecular Diagnostics Inc Pipeline Products by Equipment Type 5
HTG Molecular Diagnostics Inc Pipeline Products by Indication 6
HTG Molecular Diagnostics Inc, Key Facts 7
HTG Molecular Diagnostics Inc, Major Products and Services 8
HTG Molecular Diagnostics Inc Number of Pipeline Products by Development Stage 9
HTG Molecular Diagnostics Inc Pipeline Products Summary by Development Stage 10
Companion Diagnostic Test - B-Cell Malignancy - Product Status 11
Companion Diagnostic Test - B-Cell Malignancy - Product Description 11
COPD Risk Stratification Test - Product Status 12
COPD Risk Stratification Test - Product Description 12
Diagnostic Test - Breast Cancer - Product Status 13
Diagnostic Test - Breast Cancer - Product Description 13
Diagnostic Test - Lung Cancer - Product Status 14
Diagnostic Test - Lung Cancer - Product Description 14
Diagnostic Test - Lymphoma - Product Status 15
Diagnostic Test - Lymphoma - Product Description 15
Diagnostic Test - Melanoma - Product Status 16
Diagnostic Test - Melanoma - Product Description 16
Heart Transplant Rejection Blood Test - Product Status 17
Heart Transplant Rejection Blood Test - Product Description 17
HTG EdgeSeq ALKPlus Assay - Product Status 18
HTG EdgeSeq ALKPlus Assay - Product Description 18
HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 - Product Status 19
HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 - Product Description 19
HTG JANUS - Product Status 20
HTG JANUS - Product Description 20
I/O Suite - Product Status 21
I/O Suite - Product Description 21
Ion PGM Dx System - Cancer Assay - Product Status 22
Ion PGM Dx System - Cancer Assay - Product Description 22
Ion PGM Dx System - Genetic Disorder Assay - Product Status 23
Ion PGM Dx System - Genetic Disorder Assay - Product Description 23
NGS-based Theranostic Tool - Product Status 24
NGS-based Theranostic Tool - Product Description 24
HTG Molecular Diagnostics Inc, Key Employees 26

List of Figures
HTG Molecular Diagnostics Inc Pipeline Products by Equipment Type 6
HTG Molecular Diagnostics Inc Pipeline Products by Development Stage 9

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *